What to expect from CAR T-cell therapy for multiple myeloma

CAR T-cell therapy begins with a consultation to confirm that the treatment fits your multiple myeloma history, previous therapies, blood results, organ function, and current condition. T cells are collected from your blood and altered in a laboratory to recognise a target on myeloma cells. The process is personalised, and your team explains what happens while the cells are prepared.

Before infusion, preparative chemotherapy makes room for the modified cells. After the cells are returned through an intravenous line, the immune system may become highly active. The centre will monitor temperature, blood pressure, oxygen levels, neurological function, and blood counts. Low blood counts and infection risk may persist after the early monitoring period.

Organise a caregiver and transport, and follow the centre’s instructions about staying nearby. Report fever, cough, diarrhoea, dental problems, or other infection concerns before treatment. Keep a medicine list and do not start supplements or new medicines without checking. After discharge, attend blood tests and reviews, protect yourself from infection as advised, and delay driving until the team says your concentration and reactions are reliable.

Fatigue, nausea, headache, chills, and reduced appetite can occur. Your team can provide medicines and practical support. Follow instructions about fluids and activity, especially if bone pain, weakness, or kidney concerns are part of your myeloma care.

Seek urgent advice for fever or chills, breathing trouble, dizziness, fainting, severe weakness, confusion, difficulty speaking, new tremors, a seizure, or a rapidly worsening headache. Tell emergency staff that you have received CAR T-cell therapy. Prompt assessment matters because immune reactions and neurological effects may need hospital treatment.

Ask how your prior myeloma treatments affect eligibility, what happens if the cells take time to manufacture, how pain and bone health will be managed, which tests track response, how infection prevention will work, and who remains available after discharge.